Synchronized cardioversion: Difference between revisions
Ostermayer (talk | contribs) (Text replacement - "Category:Cards" to "Category:Cardiology") |
No edit summary |
||
(12 intermediate revisions by 6 users not shown) | |||
Line 1: | Line 1: | ||
''See [[critical care quick reference]] for doses by weight.'' | ''See [[critical care quick reference]] for doses by weight.'' | ||
==Background== | |||
*Low energy shock synchronized with peak of QRS complex | |||
*Machine leads synchronized with patient's EKG rhythm | |||
{{Defibrillation and cardioversion indications}} | {{Defibrillation and cardioversion indications}} | ||
Line 9: | Line 12: | ||
*Defibrillator | *Defibrillator | ||
*Consider sedation medication in conscious patient (e.g. etomidate, ketamine), but do not delay procedure in unstable patient | *Consider sedation medication in conscious patient (e.g. etomidate, ketamine), but do not delay procedure in unstable patient | ||
**Give [[fentanyl]] 1 μg/kg before sedation, and consider slow 0.5 mg/kg [[lidocaine]] IV 1 min before sedative | |||
**[[Etomidate]] superior to [[propofol]] in terms of recovery and hemodynamic stability<ref>Desai PM, Kane D, Sarkar MS. Cardioversion: What to choose? Etomidate or propofol. Ann Card Anaesth. 2015;18(3):306–311. doi:10.4103/0971-9784.159798.</ref> | |||
***Etomidate 0.1 mg/kg, followed by etomidate second dose of 0.05 mg/kg just prior to shock | |||
***VS propofol 1 mg/kg, followed by propofol second dose of 0.5 mg/kg just prior to shock | |||
==Procedure== | ==Procedure== | ||
===Cardioversion=== | ===Cardioversion=== | ||
*Apply pads | *Apply pads | ||
*Select appropriate | **Anterior-Posterior placement is preferred <ref>Kirchhof P et al. Anterior-posterior versus anterior-lateral electrode positions for external cardioversion of atrial fibrillation: A randomised trial. Lancet 2002 Oct 26; 360:1275-9</ref> but may not be as important as previously thought and most studies are for atrial fibrillation or flutter <ref>Kirkland S et al. The efficacy of pad placement for electrical cardioversion of atrial fibrillation/flutter: A systematic review. Acad Emerg Med. 2014 Jul;21(7):717-26</ref> | ||
***Avoid placing in close proximity to implanted devices if possible <ref>Manegold J. External cardioversion of atrial fibrillation in patients with implanted pacemaker or cardioverter-defibrillator systems: A randomized comparison of monophasic and biphasic shock energy application. European Heart Journal, 28(14);1731–1738</ref> | |||
*Select appropriate energy (Joules) | |||
*Ensure machine is "synced" before each discharge | *Ensure machine is "synced" before each discharge | ||
* | **Most machines show an indicator (arrow or dot) above each beat if appropriately synchronized | ||
*Ensure R or S wave is bigger than T wave | *Ensure R or S wave is bigger than T wave | ||
**Machine may read T wave as depolarization and shock during an actual repolarization phase | **Machine may read T wave as depolarization and shock during an actual repolarization phase | ||
**May induce shock on T and subsequent VT/VF | **May induce shock on T and subsequent VT/VF | ||
**Move leads to avoid this | **Move leads to avoid this | ||
*Give sedation, if indicated | |||
**All awake and hemodynamically stable patients | |||
*Ensure safety of environment prior to cardioversion | |||
**Nobody touching patient | |||
**Nobody touching equipment that is touching patient | |||
**Consider removing supplemental oxygen | |||
*Cardiovert | |||
**Hold 'Shock' button until shock discharged | |||
***Shock delayed until peak of QRS complex in synchronized cardioversion (keep holding button down) | |||
*Repeat PRN | |||
**May require escalating energy | |||
===Doses=== | ===Doses=== | ||
Initial recommendations: | Initial recommendations: | ||
*Tachycardia with pulse | *Tachycardia with pulse | ||
**Narrow regular: 50-100 J | **Narrow regular (SVT): 50-100 J | ||
**Narrow irregular | **Narrow irregular (A fib, A flutter) | ||
***Biphasic: 120-200 J | ***Biphasic: 120-200 J (may start as low as 50 - 100 J for A flutter) | ||
***Monophasic: 200 J | ***Monophasic: 200 J | ||
**Wide regular: 100 J | **Wide regular (VT with pulse): 100 J | ||
**Wide irregular: [[defibrilate]] (NOT synchronized) | **Wide irregular: [[defibrilate]] (NOT synchronized) | ||
Line 39: | Line 57: | ||
*[[PALS (Main)]] | *[[PALS (Main)]] | ||
*[[Defibrillation]] | *[[Defibrillation]] | ||
*[[In-Training Exam Review]] | |||
==External Links== | ==External Links== | ||
*[https://www.merckmanuals.com/professional/cardiovascular-disorders/arrhythmias-and-conduction-disorders/direct-current-dc-cardioversion-defibrillation?query=synchronized%20cardioversion Merk Manual - Direct-Current Cardioversion-Defibrillation] | |||
===Videos=== | |||
*Larry Mellick-live demonstration (https://www.youtube.com/watch?v=uCETUw0Bssw) | |||
{{#widget:YouTube|id=T7Zv9vLdWtE}} | |||
==References== | ==References== |
Latest revision as of 11:55, 24 July 2021
See critical care quick reference for doses by weight.
Background
- Low energy shock synchronized with peak of QRS complex
- Machine leads synchronized with patient's EKG rhythm
Indications
It is important to note that the procedure and indications differ between defibrillation and cardioversion
Defibrillation (Unsynchronized Cardioversion)
Synchronized Cardioversion
- Supraventricular tachycardia (SVT)
- Atrial fibrillation
- Atrial flutter
- Ventricular tachycardia with a pulse
Contraindications
- None
Equipment Needed
- Defibrillator
- Consider sedation medication in conscious patient (e.g. etomidate, ketamine), but do not delay procedure in unstable patient
- Give fentanyl 1 μg/kg before sedation, and consider slow 0.5 mg/kg lidocaine IV 1 min before sedative
- Etomidate superior to propofol in terms of recovery and hemodynamic stability[1]
- Etomidate 0.1 mg/kg, followed by etomidate second dose of 0.05 mg/kg just prior to shock
- VS propofol 1 mg/kg, followed by propofol second dose of 0.5 mg/kg just prior to shock
Procedure
Cardioversion
- Apply pads
- Select appropriate energy (Joules)
- Ensure machine is "synced" before each discharge
- Most machines show an indicator (arrow or dot) above each beat if appropriately synchronized
- Ensure R or S wave is bigger than T wave
- Machine may read T wave as depolarization and shock during an actual repolarization phase
- May induce shock on T and subsequent VT/VF
- Move leads to avoid this
- Give sedation, if indicated
- All awake and hemodynamically stable patients
- Ensure safety of environment prior to cardioversion
- Nobody touching patient
- Nobody touching equipment that is touching patient
- Consider removing supplemental oxygen
- Cardiovert
- Hold 'Shock' button until shock discharged
- Shock delayed until peak of QRS complex in synchronized cardioversion (keep holding button down)
- Hold 'Shock' button until shock discharged
- Repeat PRN
- May require escalating energy
Doses
Initial recommendations:
- Tachycardia with pulse
- Narrow regular (SVT): 50-100 J
- Narrow irregular (A fib, A flutter)
- Biphasic: 120-200 J (may start as low as 50 - 100 J for A flutter)
- Monophasic: 200 J
- Wide regular (VT with pulse): 100 J
- Wide irregular: defibrilate (NOT synchronized)
Complications
See Also
External Links
Videos
- Larry Mellick-live demonstration (https://www.youtube.com/watch?v=uCETUw0Bssw)
{{#widget:YouTube|id=T7Zv9vLdWtE}}
References
- AHA 2010 ACLS Recommendations
- ↑ Desai PM, Kane D, Sarkar MS. Cardioversion: What to choose? Etomidate or propofol. Ann Card Anaesth. 2015;18(3):306–311. doi:10.4103/0971-9784.159798.
- ↑ Kirchhof P et al. Anterior-posterior versus anterior-lateral electrode positions for external cardioversion of atrial fibrillation: A randomised trial. Lancet 2002 Oct 26; 360:1275-9
- ↑ Kirkland S et al. The efficacy of pad placement for electrical cardioversion of atrial fibrillation/flutter: A systematic review. Acad Emerg Med. 2014 Jul;21(7):717-26
- ↑ Manegold J. External cardioversion of atrial fibrillation in patients with implanted pacemaker or cardioverter-defibrillator systems: A randomized comparison of monophasic and biphasic shock energy application. European Heart Journal, 28(14);1731–1738